Potentially inappropriate medication in older participants of the Berlin Aging Study II (BASE-II) #_#x2013; Sex differences and associations with morbidity and medication use

1 Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Lipid Clinic at the Interdisciplinary Metabolism Center, Berlin, Germany, 2 Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institut für Klinische Pharmakologie und Toxikologie, Berlin, Germany, 3 Medizinische Klinik mit Schwerpunkt Nephrologie und Internistische Intensivmedizin, CharitéUniversitätsmedizin, Berlin, Germany, 4 Berlin Insitute of Health Center for Regenerative Therapies”oder ausführlicher „Charité—Universitätsmedizin Berlin, BCRT—Berlin Institute of Health Center for Regenerative Therapies, Berlin, Germany

[1]  Allison H. Oakes,et al.  Factors associated with potentially inappropriate medication use in community‐dwelling older adults in the United States: a systematic review , 2019, The International journal of pharmacy practice.

[2]  A. Nobili,et al.  Drug-drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients. , 2019, European journal of internal medicine.

[3]  E. Hak,et al.  Trends in polypharmacy and dispensed drugs among adults in the Netherlands as compared to the United States , 2019, PloS one.

[4]  C. Walker Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac , 2018, International journal of rheumatology.

[5]  M. Zins,et al.  Association Between Potentially Inappropriate Medications and Frailty in the Early Old Age: A Longitudinal Study in the GAZEL Cohort. , 2018, Journal of the American Medical Directors Association.

[6]  F. Jessen,et al.  Perspective of elderly patients on chronic use of potentially inappropriate medication – Results of the qualitative CIM-TRIAD study , 2018, PloS one.

[7]  V. Paniz,et al.  Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria , 2018, European Journal of Clinical Pharmacology.

[8]  L. Hemmy,et al.  Over-the-Counter Supplement Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia , 2018, Annals of Internal Medicine.

[9]  Charles E. Leonard,et al.  Comparative risk of serious hypoglycemia with oral antidiabetic monotherapy: A retrospective cohort study , 2018, Pharmacoepidemiology and drug safety.

[10]  Gillian E. Caughey,et al.  What is polypharmacy? A systematic review of definitions , 2017, BMC Geriatrics.

[11]  A. L. Lucchetti,et al.  Comparison of four criteria for potentially inappropriate medications in Brazilian community‐dwelling older adults , 2017, Geriatrics & gerontology international.

[12]  U. Dydak,et al.  Association of exposure to manganese and iron with relaxation rates R1 and R2*‐ magnetic resonance imaging results from the WELDOX II study , 2017, Neurotoxicology.

[13]  D. Fick,et al.  Determinants of Potentially Inappropriate Medication Use among Community‐Dwelling Older Adults , 2017, Health services research.

[14]  A. Majeed,et al.  Current and future perspectives on the management of polypharmacy , 2017, BMC Family Practice.

[15]  S. Albert,et al.  Over-the-counter medications containing diphenhydramine and doxylamine used by older adults to improve sleep , 2017, International Journal of Clinical Pharmacy.

[16]  M. Gustafsson,et al.  An evaluation of the prevalence of potentially inappropriate medications in older people with cognitive impairment living in Northern Sweden using the EU(7)-PIM list , 2017, European Journal of Clinical Pharmacology.

[17]  E. Steinhagen-Thiessen,et al.  Prevalence of Impaired Kidney Function in the German Elderly: Results from the Berlin Aging Study II (BASE-II) , 2017, Gerontology.

[18]  H. Brenner,et al.  Is Polypharmacy Associated with Frailty in Older People? Results From the ESTHER Cohort Study , 2017, Journal of the American Geriatrics Society.

[19]  E. Steinhagen-Thiessen,et al.  Relative Leukocyte Telomere Length, Hematological Parameters and Anemia - Data from the Berlin Aging Study II (BASE-II) , 2016, Gerontology.

[20]  E. Mehuys,et al.  Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review , 2015, European Journal of Clinical Pharmacology.

[21]  M. Petzold,et al.  Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study , 2015, European Journal of Clinical Pharmacology.

[22]  J. Fastbom,et al.  Association between drug‐specific indicators of prescribing quality and quality of drug treatment: a validation study , 2015, Pharmacoepidemiology and drug safety.

[23]  G. Meyer,et al.  The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries , 2015, European Journal of Clinical Pharmacology.

[24]  Michael L. Johnson,et al.  Potentially Inappropriate Anticholinergic Medication Use in Community-Dwelling Older Adults: A National Cross-Sectional Study , 2015, Drugs & Aging.

[25]  Paul Gallagher,et al.  STOPP/START criteria for potentially inappropriate prescribing in older people: version 2 , 2014, Age and ageing.

[26]  O. Senn,et al.  Potentially Inappropriate Medication Use in Older Patients in Swiss Managed Care Plans: Prevalence, Determinants and Association with Hospitalization , 2014, PloS one.

[27]  Shu-Chen Li,et al.  Cohort profile: The Berlin Aging Study II (BASE-II). , 2014, International journal of epidemiology.

[28]  P. Ihle,et al.  Prescribing potentially inappropriate medication (PIM) in Germany's elderly as indicated by the PRISCUS list. An analysis based on regional claims data , 2013, Pharmacoepidemiology and drug safety.

[29]  A. Calderón-Larrañaga,et al.  Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well? , 2012, The British journal of general practice : the journal of the Royal College of General Practitioners.

[30]  J. Hippisley-Cox,et al.  Antidepressant use and risk of adverse outcomes in older people: population based cohort study , 2011, BMJ : British Medical Journal.

[31]  M. Egger,et al.  Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis , 2011, BMJ : British Medical Journal.

[32]  J. Manson,et al.  Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. , 2010, JAMA.

[33]  Sven Schmiedl,et al.  Potentially inappropriate medications in the elderly: the PRISCUS list. , 2010, Deutsches Arzteblatt international.

[34]  D. Nathan Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes , 2009, Diabetes Care.

[35]  Lewis H Kuller,et al.  Ginkgo biloba for prevention of dementia: a randomized controlled trial. , 2008, JAMA.

[36]  P. Gallagher,et al.  STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. , 2008, International journal of clinical pharmacology and therapeutics.

[37]  L. Merle,et al.  Potentially inappropriate medications in the elderly: a French consensus panel list , 2007, European Journal of Clinical Pharmacology.

[38]  M. Beers,et al.  Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. , 2003, Archives of internal medicine.

[39]  G. Harewood Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. , 1999, The New England journal of medicine.

[40]  M. Beers,et al.  Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. , 1997, Archives of internal medicine.

[41]  R. Tamblyn,et al.  Defining inappropriate practices in prescribing for elderly people: a national consensus panel. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[42]  G. Waldemar,et al.  Changes in the Prevalence of Polypharmacy in People with and without Dementia from 2000 to 2014: A Nationwide Study. , 2019, Journal of Alzheimer's disease : JAD.

[43]  P. Thürmann,et al.  [Which factors are associated with the use of potentially inadequate medications (PIM) in the elderly? : Results from the German health interview and examination survey (DEGS1)]. , 2018, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.

[44]  E. Steinhagen-Thiessen,et al.  Polypharmacy as a Risk Factor for Clinically Relevant Sarcopenia: Results From the Berlin Aging Study II , 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.

[45]  R. Linder,et al.  [Physicians' prescription behavior of potentially inappropriate medications for elderly people: an analysis using the PRISCUS list based on TK routine data]. , 2014, Deutsche medizinische Wochenschrift.

[46]  J. Luykx,et al.  [Choosing the correct benzodiazepine: mechanism of action and pharmacokinetics]. , 2012, Nederlands tijdschrift voor geneeskunde.

[47]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.